GlassScriptPhysician profile
Cody D Turner
NPI 1639480338
$362.10
in general payments reported to CMS, 2019-2025
11 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.22 · 2023: $31.98 · 2024: $77.20 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $348.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $70.28 | 2024-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $68.61 | 2024-2025 | Airsupra |
| Jazz Pharmaceuticals INC. | $46.39 | 2025 | |
| Electromed, INC. | $36.48 | 2025 | Smartvest |
| Stryker Corporation | $31.98 | 2023 | Mako |
| Actelion Pharmaceuticals US, INC. | $21.72 | 2025 | Opsumit |
| Verona Pharma, INC. | $19.28 | 2025 | Ohtuvayre |
| Genzyme Corporation | $19.17 | 2025 | |
| Glaxosmithkline, LLC. | $18.02 | 2025 | Nucala |
| Amgen INC. | $16.95 | 2024 | Tezspire |
| Merck Sharp & Dohme LLC | $13.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cody Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.